Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$2.70 – $7.70
94% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $60.6M | $23.8M | $71.8M | $35.3M | $97.1M | $152.4M | $112.5M | $221.1M |
| Cost of revenue | $370.1M | $438.5M | $381.1M | $18.0M | $6.3M | $7.2M | $35.9M | $38.4M |
| Gross profit | −$309.5M | −$414.7M | −$309.3M | $17.3M | $90.8M | $145.2M | $76.6M | $182.3M |
| Gross margin | -510.5% | -1741.1% | -431.1% | 49.0% | 93.5% | 95.3% | 68.1% | 82.5% |
| R&D | $370.1M | $438.5M | $381.1M | $414.2M | $383.3M | $293.6M | $143.7M | $101.0M |
| Operating income | −$371.1M | −$482.4M | −$410.6M | −$613.0M | −$803.0M | −$255.1M | −$232.0M | −$116.4M |
| EBITDA | −$351.5M | −$456.9M | −$420.6M | −$588.8M | −$783.1M | −$254.6M | −$225.3M | −$45.5M |
| Net income | −$386.4M | −$493.6M | −$444.8M | −$634.6M | −$827.9M | −$297.9M | −$263.8M | −$112.1M |
| Net margin | -637.4% | -2072.3% | -619.8% | -1795.2% | -852.6% | -195.5% | -234.4% | -50.7% |
| EPS (diluted) | -3.06 | -3.71 | -3.11 | -3.77 | -4.67 | -1.67 | -1.45 | -0.52 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $234M | $-0.67 | $-0.84–$-0.53 | 1 |
| 2027 | $290M | $-0.41 | $-0.51–$-0.32 | 1 |
| 2028 | $371M | $-0.12 | $-0.15–$-0.09 | 1 |
| 2029 | $422M | $0.05 | $0.04–$0.06 | 1 |
Forward consensus · source: Financial Modeling Prep
IDORSIA AG REG SHARES ORD
No one on the platform currently holds IDRSF.
No tracked institution reports a position in IDRSF as of their last filing.
No one on the platform has traded IDRSF yet.
| $497M |
| — |
| LFTSFLifeTech Scientific Corporation | $0.23 | +0.00% | $1.0B | — |
| NNCSFNanosonics Limited | $2.55 | +0.00% | $762M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.
Trading at 8.3× sales vs its 9.6× historical median P/S.
Fair value ≈ $8.59 · price $7.40 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.